These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 34447376)

  • 1. Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications.
    Wang DK; Zuo Q; He QY; Li B
    Front Immunol; 2021; 12():705999. PubMed ID: 34447376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer-Current Treatment Options and Future Perspectives.
    Koustas E; Trifylli EM; Sarantis P; Papadopoulos N; Karapedi E; Aloizos G; Damaskos C; Garmpis N; Garmpi A; Papavassiliou KA; Karamouzis MV; Papavassiliou AG
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy in gastrointestinal cancer: The current scenario and future perspectives.
    Abdul-Latif M; Townsend K; Dearman C; Shiu KK; Khan K
    Cancer Treat Rev; 2020 Aug; 88():102030. PubMed ID: 32505807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy for gastrointestinal malignancies.
    Toomey PG; Vohra NA; Ghansah T; Sarnaik AA; Pilon-Thomas SA
    Cancer Control; 2013 Jan; 20(1):32-42. PubMed ID: 23302905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy resistance in esophageal cancer: Possible mechanisms and clinical implications.
    Fang P; Zhou J; Liang Z; Yang Y; Luan S; Xiao X; Li X; Zhang H; Shang Q; Zeng X; Yuan Y
    Front Immunol; 2022; 13():975986. PubMed ID: 36119033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology.
    Amedei A; Niccolai E; D'Elios MM
    Clin Dev Immunol; 2011; 2011():320571. PubMed ID: 22110523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal cancer stem cells as targets for innovative immunotherapy.
    Chivu-Economescu M; Necula LG; Matei L; Dragu DL; Neagu AI; Alexiu I; Bleotu C; Diaconu CC
    World J Gastroenterol; 2020 Apr; 26(14):1580-1593. PubMed ID: 32327907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy for gastrointestinal cancer: current status and strategies for improving efficacy.
    Elkord E; Hawkins RE; Stern PL
    Expert Opin Biol Ther; 2008 Apr; 8(4):385-95. PubMed ID: 18352844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy in Gastrointestinal Malignancies.
    Mizrahi J; Pant S
    Adv Exp Med Biol; 2020; 1244():93-106. PubMed ID: 32301012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.
    Agosti E; Zeppieri M; De Maria L; Tedeschi C; Fontanella MM; Panciani PP; Ius T
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic therapies for gastrointestinal cancers.
    Levy B; Deeken JF; Holt G; Marshall JL
    Clin Colorectal Cancer; 2005 May; 5(1):37-49. PubMed ID: 15929805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Approaches for Immune Directed Treatment for Ovarian Cancer.
    Hardwick N; Frankel PH; Cristea M
    Curr Treat Options Oncol; 2016 Mar; 17(3):14. PubMed ID: 26942589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Progress and Future Perspectives of Immunotherapy in Advanced Gastric Cancer.
    Jin X; Liu Z; Yang D; Yin K; Chang X
    Front Immunol; 2022; 13():948647. PubMed ID: 35844558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Therapy in GI Malignancies: A Review.
    Wang J; Reiss KA; Khatri R; Jaffee E; Laheru D
    J Clin Oncol; 2015 Jun; 33(16):1745-53. PubMed ID: 25918295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.
    Özdemir BC; Siefker-Radtke AO; Campbell MT; Subudhi SK
    Eur Urol Focus; 2018 Apr; 4(3):442-454. PubMed ID: 29056275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy.
    Staudt RE; Carlson RD; Snook AE
    Cancer Biol Ther; 2022 Dec; 23(1):127-133. PubMed ID: 35129050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota: impacts on gastrointestinal cancer immunotherapy.
    Lau HCH; Sung JJ; Yu J
    Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33435800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy for esophageal cancer: a 2019 update.
    Schizas D; Charalampakis N; Kole C; Mylonas KS; Katsaros I; Zhao M; Ajani JA; Psyrri A; Karamouzis MV; Liakakos T
    Immunotherapy; 2020 Feb; 12(3):203-218. PubMed ID: 32208794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Checkpoint Inhibitors in the Treatment of Gastrointestinal Malignancies: A Review of Current and Future Therapies.
    Hsu A; Mendelson L; Almhanna K
    R I Med J (2013); 2020 Apr; 103(3):33-37. PubMed ID: 32236159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
    Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.